Loading...
Loading...
The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday September 2, 2015:
Valeant Pharmaceuticals to Acquire Synergetics for $6.50/Share in CashThe Deal:
Valeant Pharmaceuticals International, Inc.
VRX announced it will acquire Synergetics USA, Inc.
SURG for $6.50 per share in cash in an upfront payment. Additionally, Synergetics shareholders will receive additional cash payments of up to $1.00 per share if specified sales milestones are achieved following the closing.
The transaction is expected to close in Q4 of 2015.
Valeant closed at $232.18 on Wednesday, a gain of 3.5%.
JBT to Acquire A&B Process Systems for $102MThe Deal:
JBT Corporation
JBT announced Wednesday, signing of a definitive agreement to acquire the shares of A&B Process Systems for $102 million. The transaction is expected to close in Q4 of 2015.
JBT closed at $34.13 Wednesday, up 6.5%.
Loading...
Loading...
:
RR Media shareholder Rapac Communication and Infrastructure Ltd. (Rapac), following a publication in Israel's
Globes, that it was informed by RR Media that RR Media was approached by an international corporation, mentioned by the publication as SES, with a non-binding preliminary indication of interest for the acquisition of RR Media. The interest is at a preliminary stage, there is no agreement on the terms of the transaction and no guarantee of a binding agreement.
RR Media shares closed at $8.22 Wednesday, a gain of 6%.
Lannett to Acquire Kremers Urban Pharmaceuticals for $1.23BThe Rumor:
Lannett Company, Inc.
LCI announced Wednesday, that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals for $1.23 billion, plus potential contingency payments. The transaction is expected to close in Q4 of calendar 2015.
Lannett shares closed at $49.48 Wednesday, and rose 23% after-hours.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in